EG23150A - Process for the purification of pharmacologically active proteins through cathionic enhance chromatography - Google Patents

Process for the purification of pharmacologically active proteins through cathionic enhance chromatography

Info

Publication number
EG23150A
EG23150A EG2002060743A EG2002060743A EG23150A EG 23150 A EG23150 A EG 23150A EG 2002060743 A EG2002060743 A EG 2002060743A EG 2002060743 A EG2002060743 A EG 2002060743A EG 23150 A EG23150 A EG 23150A
Authority
EG
Egypt
Prior art keywords
cathionic
chromatography
purification
enhance
pharmacologically active
Prior art date
Application number
EG2002060743A
Other languages
English (en)
Inventor
Lucia Scapol
Original Assignee
Alfa Wassermann Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alfa Wassermann Spa filed Critical Alfa Wassermann Spa
Application granted granted Critical
Publication of EG23150A publication Critical patent/EG23150A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/76—Albumins
    • C07K14/765—Serum albumin, e.g. HSA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/18—Ion-exchange chromatography
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C07K14/56—IFN-alpha
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/811—Interferon

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Analytical Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
EG2002060743A 2001-07-06 2002-06-29 Process for the purification of pharmacologically active proteins through cathionic enhance chromatography EG23150A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT2001BO000426A ITBO20010426A1 (it) 2001-07-06 2001-07-06 Processo per la purificazione di proteine farmacologicamente attive mediante cromatografia in scambio cationico

Publications (1)

Publication Number Publication Date
EG23150A true EG23150A (en) 2004-05-31

Family

ID=11439471

Family Applications (1)

Application Number Title Priority Date Filing Date
EG2002060743A EG23150A (en) 2001-07-06 2002-06-29 Process for the purification of pharmacologically active proteins through cathionic enhance chromatography

Country Status (27)

Country Link
US (1) US6866782B2 (da)
EP (1) EP1273592B1 (da)
JP (1) JP3940037B2 (da)
KR (1) KR100771252B1 (da)
CN (1) CN100484954C (da)
AR (1) AR034663A1 (da)
AT (1) ATE307824T1 (da)
BG (1) BG65748B1 (da)
BR (1) BR0202431A (da)
CA (1) CA2388716C (da)
CU (1) CU23149A3 (da)
DE (1) DE60206847T2 (da)
DK (1) DK1273592T3 (da)
DZ (1) DZ3236A1 (da)
EG (1) EG23150A (da)
ES (1) ES2250544T3 (da)
HR (1) HRP20020480B1 (da)
HU (1) HUP0202124A2 (da)
IT (1) ITBO20010426A1 (da)
ME (1) MEP3408A (da)
MX (1) MXPA02006303A (da)
PL (1) PL209954B1 (da)
RS (1) RS51512B (da)
RU (1) RU2274471C2 (da)
SI (1) SI1273592T1 (da)
SK (1) SK287827B6 (da)
UY (1) UY27354A1 (da)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1628729A2 (en) 2003-05-16 2006-03-01 Cryobiophysica, Inc. External gradient chromatofocusing
WO2005100379A1 (ja) * 2004-03-30 2005-10-27 Hiroshi Yanagisawa タンパク質の分離方法
US7943046B2 (en) * 2004-10-01 2011-05-17 Agilent Technologies, Inc Methods and systems for on-column protein delipidation
US7449116B2 (en) * 2004-10-01 2008-11-11 Agilent Technologies, Inc. Methods and systems for protein separation
HU230758B1 (hu) * 2006-04-12 2018-03-28 Crealta Pharmaceuticals LLC 100% Fehérjék tisztítása kationos felületaktív anyaggal
US20100261275A1 (en) * 2007-12-10 2010-10-14 Yves Durocher Production of Recombinant Interferon Proteins
DE102009032179A1 (de) 2009-07-07 2011-01-13 Biogenerix Ag Verfahren zur Reinigung von Interferon beta
CN101768601B (zh) * 2010-02-01 2013-08-07 山东泉港药业有限公司 一种重组人血白蛋白—干扰素α2b的生产方法
SG10201605397PA (en) * 2011-07-01 2016-08-30 Hoffmann La Roche Method For Separation Of Monomeric Polypeptides From Aggregated Polypeptides
US8921113B2 (en) 2012-12-21 2014-12-30 Dionex Corporation Buffer kit and method of generating a linear pH gradient
WO2014137903A2 (en) 2013-03-08 2014-09-12 Genzyme Corporation Integrated continuous manufacturing of therapeutic protein drug substances
CN104236983A (zh) * 2013-06-14 2014-12-24 中国科学院大连化学物理研究所 溶液样品中含长烷基链的离子液体的去除方法
TWI671312B (zh) 2014-01-17 2019-09-11 美商健臻公司 無菌層析法及製法
TWI709569B (zh) 2014-01-17 2020-11-11 美商健臻公司 無菌層析樹脂及其用於製造方法的用途
WO2016079598A1 (en) * 2014-11-18 2016-05-26 Unichem Laboratories Limited An improved process for the preparation of pharmacopoeial grade interferon alpha 2b
CN106496302B (zh) * 2015-09-08 2021-12-10 三生国健药业（上海）股份有限公司 一种用离子交换层析纯化蛋白质的方法
GB201517450D0 (en) * 2015-10-02 2015-11-18 Ipsen Biopharm Ltd Method
CN108367245A (zh) * 2015-12-09 2018-08-03 巴斯夫欧洲公司 在解吸条件下从发酵固体纯化蛋白质的方法
GB2568936B (en) 2017-12-01 2019-12-25 Ford Global Tech Llc Liquid cooled injector
US11369703B2 (en) 2018-08-31 2022-06-28 Genzyme Corporation Sterile chromatography resin and use thereof in manufacturing processes
US11022585B2 (en) * 2019-06-09 2021-06-01 Dionex Corporation Methods and systems for optimizing buffer conditions with liquid chromatography
CN111138523A (zh) * 2019-12-10 2020-05-12 天津生机集团股份有限公司 一种从重组鸡干扰素α复性液中纯化制备重组鸡干扰素α的方法
CN113968900B (zh) * 2020-07-23 2023-07-25 中元汇吉生物技术股份有限公司 一种纯化C1q蛋白的方法
CN115918902A (zh) * 2022-12-19 2023-04-07 新疆农业科学院农业质量标准与检测技术研究所 一种通过微水波扩散重力法预处理葡萄脱水并获取高酚葡萄提取物的方法

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4228154A (en) * 1979-02-26 1980-10-14 Armour Pharmaceutical Company Purification of plasma albumin by ion exchange chromatography
US4534906A (en) * 1982-11-01 1985-08-13 Genentech, Inc. Removal of impurities from human leukocyte interferon preparations
DE3515336C2 (de) * 1985-04-27 1994-01-20 Boehringer Ingelheim Int Verfahren zur Herstellung und Reinigung von â-Interferon
US5037644A (en) * 1986-10-27 1991-08-06 Cetus Corporation Pharmaceutical compositions of recombinant interleukin-2 and formulation processes
US4732683A (en) * 1986-12-02 1988-03-22 Biospectrum, Inc. Purification method for alpha interferon
US4765903A (en) * 1987-10-06 1988-08-23 Interferon Sciences, Inc. Purification of monomeric interferon
US5250662A (en) * 1989-10-05 1993-10-05 Alpha Therapeutic Corporation Albumin purification
US5849874A (en) * 1991-07-12 1998-12-15 Gist-Brocades, N.V. Process for the purification of serum albumin
IT1262899B (it) * 1992-03-27 1996-07-22 Sclavo Spa Processo per l'isolamento di fattore ix, fattore x e fattore ii altamente purificati dal complesso protrombinico o dal plasma umano
US5440018A (en) * 1992-05-20 1995-08-08 The Green Cross Corporation Recombinant human serum albumin, process for producing the same and pharmaceutical preparation containing the same
US5521287A (en) * 1992-05-20 1996-05-28 The Green Cross Corporation Recombinant human serum albumin, process for producing the same and pharmaceutical preparation containing the same
US5728553A (en) * 1992-09-23 1998-03-17 Delta Biotechnology Limited High purity albumin and method of producing
US5367054A (en) * 1993-04-12 1994-11-22 Stolle Research & Development Corp. Large-scale purification of egg immunoglobulin
DK0679718T3 (da) * 1994-04-09 2001-10-22 Hoffmann La Roche Fremgangsmåde til fremstilling af alfa-interferon
JP3702474B2 (ja) * 1994-06-01 2005-10-05 三菱ウェルファーマ株式会社 血清アルブミン製剤の製造方法
US5486470A (en) * 1994-07-21 1996-01-23 Merck & Co., Inc. Purified herpes simplex virus protease and methods of purification
DE69532492T2 (de) 1994-08-31 2004-12-02 Mitsubishi Pharma Corp. Verfahren zur Reinigung von rekombinantem menschlichem Serumalbumin
EP0871671A1 (en) * 1995-09-07 1998-10-21 PPL Therapeutics (Scotland) Limited Purification of alpha-1 proteinase inhibitor
GB9902000D0 (en) 1999-01-30 1999-03-17 Delta Biotechnology Ltd Process

Also Published As

Publication number Publication date
KR100771252B1 (ko) 2007-10-30
ATE307824T1 (de) 2005-11-15
CA2388716C (en) 2008-01-08
JP2003096092A (ja) 2003-04-03
ES2250544T3 (es) 2006-04-16
RU2274471C2 (ru) 2006-04-20
EP1273592A3 (en) 2003-03-19
HRP20020480B1 (en) 2006-11-30
KR20030005005A (ko) 2003-01-15
HRP20020480A2 (en) 2003-02-28
YU50502A (sh) 2005-09-19
RU2002117383A (ru) 2004-01-27
CN1396176A (zh) 2003-02-12
SI1273592T1 (sl) 2006-02-28
CN100484954C (zh) 2009-05-06
PL209954B1 (pl) 2011-11-30
CU23149A3 (es) 2006-06-29
ITBO20010426A1 (it) 2003-01-06
ITBO20010426A0 (it) 2001-07-06
BR0202431A (pt) 2003-09-09
CA2388716A1 (en) 2003-01-06
AR034663A1 (es) 2004-03-03
US6866782B2 (en) 2005-03-15
JP3940037B2 (ja) 2007-07-04
SK8592002A3 (en) 2003-01-09
BG106768A (en) 2003-05-30
RS51512B (sr) 2011-06-30
EP1273592B1 (en) 2005-10-26
EP1273592A2 (en) 2003-01-08
HU0202124D0 (da) 2002-09-28
MEP3408A (en) 2010-10-10
SK287827B6 (sk) 2011-11-04
MXPA02006303A (es) 2003-02-10
UY27354A1 (es) 2003-04-30
HUP0202124A2 (hu) 2003-10-28
DE60206847D1 (de) 2005-12-01
DE60206847T2 (de) 2006-07-06
DK1273592T3 (da) 2006-01-02
DZ3236A1 (fr) 2005-04-20
US20030010715A1 (en) 2003-01-16
BG65748B1 (bg) 2009-09-30
PL354769A1 (en) 2003-01-13

Similar Documents

Publication Publication Date Title
EG23150A (en) Process for the purification of pharmacologically active proteins through cathionic enhance chromatography
IL146389A0 (en) Process for the preparation of dronedarone
EP1380589A4 (en) PROTEIN CLEANING METHOD
GC0000391A (en) Process for the preparation of urea
IL143106A (en) Process for the preparation of diphenylmethylthioacetamide
EP1646353A4 (en) FUSION PROTEINS FOR THE TREATMENT OF THE CENTRAL NERVOUS SYSTEM
HUP0302530A3 (en) Process for the purification of 2-nitro-4-methylsulphonylbenzoic acid
IL162385A0 (en) Process for the preparation of echinocandin derivatives
IL150600A0 (en) Process for the preparation of peptides
IL162172A0 (en) Methods for the purification of levofloxacin
DK1392722T3 (da) Fremgangsmåde vedrörende echinocandiner
SI1656455T1 (sl) Postopek za čiščenje rekombinantnih polipeptidov
EP1419428A4 (en) STRATEGY BASED ON ASSEMBLIES FOR PRODUCING PROTEIN-BASED PHARMACEUTICAL PRODUCTS
HUP0303025A3 (en) Process for the preparation of arylethanoldiamines
HUP0400981A3 (en) Polypeptide purification method
PL371583A1 (en) Process for the preparation of 7alpha-methylsteroids
SG111997A1 (en) Improved process for the preparation of polyalkylphenoxyaminoalkanes
GB0113300D0 (en) Purification process
IL164788A0 (en) Process for the preparation of 3-isochromanone
GB0116022D0 (en) Purification process
PL368905A1 (en) Process for the preparation of beta-ionylideneacetaldehyde
FR2829759B1 (fr) Procede de preparation de polyhydroxystilbenes symetriques
PL376745A1 (pl) Proces oczyszczania białek wiążących TNF przy użyciu IMAC
SI1395580T1 (en) Method for the purification of triazolylmethylepoxides
FR2848221B1 (fr) Procede de preparation d'heterocarpine recombinante